Kenneth P Greenberg

Title: Kenneth P. Greenberg: Innovator in Oncolytic Viral Vectors

Introduction

Kenneth P. Greenberg is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer treatment through his innovative work on oncolytic viral vectors. With a total of 2 patents, his research focuses on utilizing recombinant viral vectors for the treatment and prevention of cancer.

Latest Patents

Kenneth's latest patents revolve around oncolytic viral vectors and their applications. The present disclosure relates to recombinant viral vectors designed for cancer treatment and prevention. These vectors incorporate several advanced features, including viral replication restriction by inserting tumor-suppressive microRNA (miRNA) target sequences into the viral genome. Additionally, they aim to disrupt oncogenic miRNA function, remodel the cancer microenvironment, and target cancer cells by incorporating protease-activated antibodies into the viral particle.

Career Highlights

Kenneth P. Greenberg has established himself as a key figure in the biotechnology sector. He is currently associated with Oncorus, Inc., where he continues to advance his research in oncolytic viral therapies. His work has the potential to revolutionize cancer treatment and improve patient outcomes.

Collaborations

Kenneth collaborates with various professionals in the field, including his coworker Mitchell H. Finer. Their combined expertise contributes to the innovative research and development at Oncorus, Inc.

Conclusion

Kenneth P. Greenberg's contributions to the field of cancer treatment through his patents on oncolytic viral vectors highlight his role as a leading inventor. His work not only showcases his innovative spirit but also holds promise for future advancements in cancer therapies.